- Home
- CNTA vs FLR Comparison
CNTA vs FLR Comparison
Compare CNTA & FLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | FLR |
|---|---|---|
| Founded | 2020 | 1912 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.7B |
| IPO Year | 2021 | 2006 |
Fundamental Metrics
Financial Performance| Metric | CNTA | FLR |
|---|---|---|
| Price | $39.50 | $50.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | $43.17 | ★ $53.50 |
| AVG Volume (30 Days) | ★ 4.9M | 1.9M |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,000,000.00 | ★ $15,503,000,000.00 |
| Revenue This Year | N/A | $6.56 |
| Revenue Next Year | N/A | $7.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.95 | $33.82 |
| 52 Week High | $40.26 | $57.50 |
Technical Indicators
Market Signals| Indicator | CNTA | FLR |
|---|---|---|
| Relative Strength Index (RSI) | 73.71 | 59.30 |
| Support Level | $39.16 | $42.92 |
| Resistance Level | $40.26 | $51.43 |
| Average True Range (ATR) | 0.22 | 1.46 |
| MACD | -0.45 | 0.22 |
| Stochastic Oscillator | 52.34 | 72.94 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About FLR Fluor Corporation
Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services.It serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $15.5 billion in revenue in 2025.